Patients beginning treatment with semaglutide can expect a gradual weight loss trajectory
People who should be vaccinated: Pneumococcal vaccine is recommended for people aged 65 and over, people with chronic heart, lung, liver, kidney disease, diabetes, splenectomy, hypersplenism cases, regardless of age group, HIV-infected patients, those who have undergone solid organ and hematopoietic stem cell transplantation, and those who have been using immunosuppressive drugs such as corticosteroids for a long time
Its approval was preceded by the outcomes of five phase III trials, which are summarized in Tables 1 and 2, each of which compare tirzepatide at 5 mg, 10 mg, and 15 mg to other medications comparing similar clinical endpoints
R., Pande, V